Two Patients with Antiphospholipid Antibody Developed Disseminated Intravascular Coagulation

被引：3

作者：

Habe, Koji ^{[1
]}

Wada, Hideo ^{[2
]}

Ito-Habe, Naomi ^{[3
]}

Suzuki, Hikoji ^{[4
]}

Nobori, Tsutomu ^{[2
]}

Mizutani, Hitoshi ^{[1
]}

机构：

[1] Mie Univ, Grad Sch Med, Dept Dermatol, Tsu, Mie, Japan

[2] Mie Univ, Grad Sch Med, Dept Mol & Lab Med, Tsu, Mie, Japan

[3] Mie Univ, Grad Sch Med, Dept Hematol & Oncol, Tsu, Mie, Japan

[4] Suzuka Kaisei Hosp, Dept Internal Med, Suzuka, Mie, Japan

来源：

INTERNAL MEDICINE | 2013年 / 52卷 / 02期

关键词：

DIC; APS; antiphospholipid antibody (aPL); CRITERIA; CLASSIFICATION; THROMBOSIS; APS;

D O I：

10.2169/internalmedicine.52.8308

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

One hundred and eleven patients with antiphospholipid antibodies (aPL) were diagnosed at Mie University Hospital during the past 17 years. Two of these patients developed disseminated intravascular coagulation (DIC). The first patient twice developed DIC complicated by pancreatitis and pregnancy, while in the second case, no specific causative complications for DIC were identified. The details of these cases imply that aPL is associated with DIC and/or is a potent triggering factor for DIC.

引用

页码：269 / 272

页数：4

共 10 条

[1] Pathophysiology of Thrombosis and Potential Targeted Therapies in Antiphospholipid Syndrome [J].

Amengual, Olga ;

Atsumi, Tatsuya ;

Koike, Takao .

CURRENT VASCULAR PHARMACOLOGY, 2011, 9 (05) :606-618

[2] Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome:: clinical and haematological characteristics of 23 patients [J].

Asherson, RA ;

Espinosa, G ;

Cervera, R ;

Gómez-Puerta, JA ;

Musuruana, J ;

Bucciarelli, S ;

Ramos-Casal, M ;

Martínez-González, AL ;

Ingelmo, M ;

Reverter, JC ;

Font, J ;

Triplett, DA .

ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (06) :943-946

[3]

ASHERSON RA, 1992, J RHEUMATOL, V19, P508

[4]

Bobba RS, 2007, J RHEUMATOL, V34, P1522

[5] International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) [J].

Miyakis, S ;

Lockshin, MD ;

Atsumi, T ;

Branch, DW ;

Brey, RL ;

Cervera, R ;

Derksen, RHWM ;

De Groot, PG ;

Koike, T ;

Meroni, PL ;

Reber, G ;

Shoenfeld, Y ;

Tincani, A ;

Vlachoyiannopoulos, PG ;

Krilis, SA .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (02) :295-306

[6] Tissue factor expression on monocytes induced by anti-phospholipid antibodies as a strong risk factor for thromboembolic complications in SLE patients [J].

Nojima, Junzo ;

Masuda, Yumiko ;

Iwatani, Yoshinori ;

Suehisa, Etsuji ;

Futsukaichi, Yoshiaki ;

Kuratsune, Hirohiko ;

Watanabe, Yasuyoshi ;

Takano, Toru ;

Hidaka, Yoh ;

Kanakura, Yuzuru .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 365 (01) :195-200

[7] APS - controversies in diagnosis and management, critical overview of current guidelines [J].

Pengo, Vittorio .

THROMBOSIS RESEARCH, 2011, 127 :S51-S52

[8] Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation - On behalf of the Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH) [J].

Taylor, FB ;

Toh, CH ;

Hoots, WK ;

Wada, H ;

Levi, M .

THROMBOSIS AND HAEMOSTASIS, 2001, 86 (05) :1327-1330

[9] Disseminated intravascular coagulation [J].

Wada, H .

CLINICA CHIMICA ACTA, 2004, 344 (1-2) :13-21

[10]

Willis R, 2012, SEMIN THROMB HEMOST

← 1 →